Edition:
United Kingdom

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.73USD
14 Dec 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.73
Open
$1.70
Day's High
$1.74
Day's Low
$1.66
Volume
65,667
Avg. Vol
88,779
52-wk High
$10.90
52-wk Low
$1.53

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

David U'Prichard

68 2006 Independent Chairman of the Board

Spiro Rombotis

57 2006 President, Chief Executive Officer, Director

Christopher Henney

76 2009 Independent Vice Chairman of the Board

Paul McBarron

55 2009 Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Secretary, Director

Judy Chiao

56 2006 Vice President - Clinical Development and Regulatory Affairs